Ashland to acquire AkzoNobel's Zeta Fraction biofunctional technology
Ashland announced an agreement to purchase the Zeta Fraction technology from AkzoNobel. The acquisition broadens Ashland's value-added portfolio in the personal care, pharmaceutical, food and beverage, and agriculture markets. Financial terms were not disclosed. July 02, 2015